The success story of India's paediatric vaccination programme should be replicated in the form of an adult vaccination programme, experts recommended at the 2nd edition of the India Vaccine Leaders Conclave (IVLC) in Mumbai on the theme...
Drug maker Lupin said it has received approval from the US health regulator to market a generic product, used in the treatment of a lung disease, in the American market. The firm has received approval from the US Food and Drug Administration...
The global cancer vaccines market was valued at USD 6.43 billion in 2021 and is expected to grow at a CAGR of 14.7% from USD 7.32 billion in 2022 to USD 19.12 billion by 2029. During the forecast period, the market is expected to grow at a ...
The first of its kind, the WHO online repository of evidence-informed decision-making (EIDM) tools highlights WHO tools as well as external tools used by WHO to facilitate knowledge translation and partner organizations involved in the process....
Indo-Euro Synchronisation (IES) has announced the groundbreaking event 'Upskilling Certification Linked to Nursing Employment in Germany' in order to foster collaborations between Germany and India. This event acted as a catalyst, highlighting...
Pyxis Oncology, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing innovative antibody therapeutics for oncology, announced the successful completion of its acquisition of Apexigen, Inc. (Apexigen),...
Indian pharmaceutical manufacturers will need to explore partnerships with governments and NGOs (non-governmental organisations) to expand access to essential medicines, according to Sunil Attavar, former president of the Karnataka Drugs...
Following in the footsteps of Nagaland, the Government of Mizoram in the country's north-east has notified the Pharmacy Practise Regulations (PPR) 2015, which rigorously demand that only licenced chemists can administer pharmaceuticals...
Agilus Diagnostics, a Fortis Healthcare Limited subsidiary, announced the opening of a new laboratory in Panjagutta. The sophisticated laboratory can process 60,000+ samples per month, ranging from simple routine tests to semi-specialized...
The central government's recently released National Policy on Research and Development and Innovation in the Pharma-MedTech Sector, according to Kiran Mazumdar-Shaw, executive chairperson of Biocon and Biocon Biologics, could be a game changer...
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")
